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Hepcidin is a liver-derived antimicrobial peptide that regulates iron absorption and is also an integral
part of the acute phase response. In a previous report, we found evidence that this peptide could also be
induced by toxic heavy metals and xenobiotics, thus broadening its teleological role as a defensin.
However it remained unclear how its sensing of disparate biotic and abiotic stressors might be integrated
at the transcriptional level. We hypothesized that its function in cytoprotection may be regulated by
NFE2-related factor 2 (Nrf2), the master transcriptional controller of cellular stress defenses. In this re-
port, we show that hepcidin regulation is inextricably linked to the acute stress response through Nrf2
signaling. Nrf2 regulates hepcidin expression from a prototypical antioxidant response element in its
promoter, and by synergizing with other basic leucine-zipper transcription factors. We also show that
polyphenolic small molecules or phytoestrogens commonly found in fruits and vegetables including the
red wine constituent resveratrol can induce hepcidin expression in vitro and post-prandially, with
concomitant reductions in circulating iron levels and transferrin saturation by one such polyphenol
quercetin. Furthermore, these molecules derepress hepcidin promoter activity when its transcription by
Nrf2 is repressed by Keap1. Taken together, the data show that hepcidin is a prototypical antioxidant
response or cytoprotective gene within the Nrf2 transcriptional circuitry. The ability of phytoestrogens to
modulate hepcidin expression in vivo suggests a novel mechanism by which diet may impact iron
homeostasis.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Although hepcidin has almost exclusively been regarded as an
iron-regulatory hormone [1], some studies suggest that it may be
functionally promiscuous. For example, our recent ﬁnding that
zinc and cadmium can induce hepcidin expression [2], suggestsr Inc. This is an open access article
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, k.srai@ucl.ac.uk (S.K.S. Srai).that it might be a sensor-regulator of (other) heavy metal toxins.
Hepcidin induction by these metals indicated parallels with MT-1,
an Nrf2 target gene that is synergistically up-regulated by metal-
responsive transcription factor -1, MTF-1, to confer protection
against cadmium toxicity [3,4]. In addition, ﬁsh in habitats that are
highly polluted with industrial chemicals expressed more hepcidin
than their fresh-water counterparts [5]. Recent reports also sug-
gest that ER stress regulates hepcidin expression [6,7], an indica-
tion that it may be a broad-spectrum stress-inducible cytopro-
tective peptide.
As the master regulator of cellular stress responses, Nrf2 con-
fers protection against xenobiotic toxicity, tissue injury and acute
inﬂammation by regulating the expression of cytoprotection
genes. As a heterodimer with the small Maf proteins (e.g. MafG),
Nrf2 binds to the cognate electrophile or antioxidant response
element to activate these genes. The signature for the ARE is the
core sequence TGACnnnGC (where n is any nucleotide); mutations
within the conserved TGAC or GC boxes severely attenuate the
antioxidant response [8,9]. Although primarily associated with
phase II genes, this element has also been identiﬁed in genes that
control processes as diverse as innate immunity, iron metabolism,
inﬂammation and wound healing [10–12]. Resistance to oxidativeunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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mice because of depleted cytoprotective protein levels [13,14]. In
spite of its importance in organismal and cellular protection, Nrf2
is repressed under normal conditions by Keap1, a Cullin3-depen-
dent ubiquitin ligase adaptor protein that sequesters Nrf2 in the
cytoplasm and targets it for ubiquitination and proteasomal de-
gradation [15,16]. In addition to Keap1, caveolin-1, SCF/β-TrCP and
RXRα also interact with and repress Nrf2 [17–19].
We hypothesized that Nrf2 might be a critical node that in-
tegrates oxidative stress responses to iron toxicity on one hand
[20,21], and the inﬂammatory response [1] on the other. We rea-
soned that hepcidin might be a member of the battery of genes
that is involved in coordinating those responses. In this report, we
show that Nrf2 may coordinate all the signals for hepcidin ex-
pression and function. We further found that phytoestrogens (re-
ferred to interchangeably here as polyphenols) modulate hepcidin
expression both in vitro and in vivo. In the latter, this induced
changes in systemic iron levels. This has consequences for un-
derstanding how diet may affect iron homeostasis.2. Materials and methods
2.1. Plasmid constructs
We ampliﬁed two overlapping fragments of 700 bp and
1.8 kb of the HAMP promoter from human genomic DNA with
the sense primer CATGGTACCAACATCCCCGGGCTCTGGTGACT. An-
tisense primers for the 1.8 kb and 700 bp promoter fragments
were CATCTCGAGCGAGGAGGAGGAGGAGCA and CATCTCGAGG-
CACCAACTCAGCCTGTGCTGCC respectively. All primers were de-
rived from GenBank Acc # AD000684. The PCR products were
digested with KpnI and XhoI (restriction sites are underlined),
puriﬁed with Geneclean (BIO101) and respectively ligated into
pGL3 Basic or pGL3 Promoter vectors (Promega), to generate
HepcP1.8luc and HepcP0.7luc.
To generate plasmids with putative HAMP antioxidant response
elements, we synthesized the following phosphorylated complementary
oligonucleotides derived from the gene: sense, CTAGCGAATTCAA-
CATCCCCGGGCTCTGGTGACTTGGCTGACACTGC; antisense, TCGAGCAGT
GTCAGCCAAGTCACCAGAGCCCGGGGATGTTGAATTCG (NheI-XhoI half-
sites are underlined); the ARE core is in bold-face. A unique EcoRI site
was included for linearization in order to conﬁrm insertion of the duplex
oligonucleotide. An oligonucleotide with a mutant ARE HepcAREMt, in
which the ARE core was mutated to GTaACTTGaCT (mutated residues
are in lower case) and its complement, were similarly synthesized. Both
pairs of oligonucleotides annealed as previously described [21], and li-
gated directionally into the NheI-XhoI sites of pGL3 Promoter vector to
give HepcARE-luc or HepcAREMt-luc. Both constructs were linearized
with EcoRI to conﬁrm insertion.
BRG1, BRM and c-Fos, plasmids were obtained from Addgene
(Cambridge, MA). Nrf1 and Nrf3 cDNAs were purchased from
Thermo Fisher Scientiﬁc. All plasmid constructs were sequenced
for veriﬁcation.
2.2. Cell culture, transfection and reporter assays
All cell culture media were obtained from Invitrogen. HepG2
cells were obtained from ECACC (Porton Down, UK) and cultured
in DMEM (with GlutaMAX-1 and high glucose), 10% FBS and an-
tibiotics and antimycotics. Cell culture, transfections and reporter
assays were performed as previously described [22]. For transac-
tivation assays, cells were co-transfected with pcDNA3-Nrf2 and
the promoter or enhancer constructs; for trans-repression, pcDNA-
Keap1 was co-transfected with pcDNA3-Nrf2 and the promoter
constructs. For derepression assays, cells transfected with Nrf2,Keap1 and the promoter plasmids were treated with DMSO or
polyphenols. C-Jun and c-Fos were also transfected with Hepc-
P1.8luc alone or with Nrf2 to determine transcriptional synergy in
hepcidin regulation.
2.3. Animals and treatments
All ﬂavonoids were obtained from Sigma and dissolved in 50%
ethanol, 10% DMSO. Male, 9-week old Sprague-Dawley rats (230–
290 g) were obtained from the Comparative Biology Unit, UCL, and
maintained ad libidum on standard RM1 diet (SDS, UK). Animal
procedures were in accordance with the British Home Ofﬁce's
Animals (Scientiﬁc Procedures) Act, 1986. Rats were injected intra-
peritoneally with 1 ml of the ﬂavonoids (50 mg/kg body weight);
control animals received 50% ethanol/10% DMSO. After 18 h, the
animals were sacriﬁced; livers were snap-frozen in liquid nitrogen
and stored at 80 °C until required. Blood was collected by cardiac
puncture into test tubes with or without potassium/EDTA; plasma
or serum respectively, were separated from blood cells by
centrifugation.
2.4. RNA extraction and gene expression analysis
Total liver RNA was extracted with TRIzol (Invitrogen) according to
the manufacturer's instructions and 1 μg of each sample was reverse
transcribed using the Verso cDNA kit (Thermo Fisher Scientiﬁc). RT-
PCR was performed using Lightcycler 1.5 (Roche) with GAPDΗ as in-
ternal standard. Each reaction was performed in duplicate and con-
tained 10 pmoles of speciﬁc primers, 1 SYBR Green Mastermix
(Qiagen) and 1 μL of cDNA in a 20 μL reaction. Samples without cDNA
were included as negative controls. Rat PCR primer-pairs were as
follows: Hamp: sense, AGACACCAACTTCCCCATATGC; antisense ACA-
GAGACCACAGGAGGAATTCTT; QR: sense, GCTTTCAGTTTTCGCCTTTG,
antisense, GAGGCCCCTAATCTGACC TC; GST: sense, AGACATCCACCT
GCTGGAAC; antisense, GGCTGCAGGAACTTCTTCAC; HO-1: sense,
TGCTCGCATGAACACTCTG; antisense, TCCTCTGTCAGCAGTGCC. Quan-
titative PCR was also performed on HepG2 cells treated with poly-
phenols. The respective primers were: HAMP: sense, CTGCAACCC-
CAGGACAGAG; antisense, GGAATAAATAAGGAAGGGAGG. GAPDH:
sense, TGGTATCGTGGAAGGACTC; antisense, AGTAGAGGCAGGGAT
GATG; HO-1: sense, GTTGGCACCATGGAGCGTCCG; antisense, AGCCG
TCTCGGGTCACCTGG. In all cases, Ct values were obtained for each
gene of interest and the GAPDH internal standard. Gene expression
was normalised to GAPDH and represented as ΔCt values. For each
sample the mean of the ΔCt values was calculated. Relative gene
expression was normalised to controls with an arbitrary expression
level of 1.0.
2.5. Recombinant Nrf2 and MafG expression
Nrf2 (subcloned into pGEX5x-1, Amersham) and MafG were
expressed as recombinant GST and His-tagged proteins respec-
tively in BL21-CodonPlus (DE3)-RIPL cells (Stratagene). Re-
combinant MafG was partially puriﬁed using the MagneHis Protein
Puriﬁcation kit (Promega) as recommended by the manufacturer.
GST-Nrf2 was partially puriﬁed with Super-Glu10 resin (Generon).
Protein integrity was veriﬁed by resolving aliquots on a 4–12%
NuPAGE Bis-Tris gel in MES buffer (Invitrogen).
2.6. Electrophoretic mobility shift assay
Nuclear extracts were prepared from HepG2 cells treated with
DMSO or with various polyphenols for 6 h. Double-stranded
HepcARE and HepcAREMt oligonucleotides (described above),
were used in mobility shift assays as previously described [21]. To
further conﬁrm ARE-binding speciﬁcity, mobility shift assays were
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nation. Nrf2/MafG heterodimers were formed by incubating equal
amounts of both proteins in EMSA binding buffer for 30 min at
room temperature. Aliquots of the heterodimers were then in-
cubated with labeled ARE probe and resolved as above. Re-
combinant GST was used as negative control.
2.7. Chromatin immunoprecipitation (ChIP) assay
HepG2 cells were treated with DMSO (0.1% ﬁnal concentration),
LPS (1 mg/mL), quercetin (50 μM), sulforaphane (10 μM) and tBHQ
(100 μM) for 6 h. Chromatin immunoprecipitation was performed
using a ChIP kit as instructed by the manufacturer (Upstate).
Chromatin was immunoprecipitated overnight with 10 μg anti-Nrf2
antibody (Santa Cruz); control ChIP sample was incubated with a
non-speciﬁc IgG (Sigma). DNA was puriﬁed using the Geneclean kit
(BIO 101). PCR was performed with 2 μL of the eluted DNA using the
following primers: AACATCCCCGGGCTCTGGTGACT and GCAC-
CAACTCAGCCTGTGCTGCC. The PCR products were resolved on a 2%
1 X TAE agarose gel.
2.8. Western blotting
HepG2 cells were treated for 6 h with DMSO or selected poly-
phenols, and known hepcidin inducers, namely LPS (10 mg/ml; E.
coli serovar 0111:B4 Sigma), and 100 ng/mL IL-6 (Peprotech). To
determine if iron could also induce Nrf2, cells were treated with
various concentrations of FeNTA; cadmium, a known inducer of
metal toxicity and of Nrf2 was also included at 10 mM. Total cell
lysates were prepared in RIPA buffer (Santa Cruz Biotechnology)
supplemented with a protease inhibitor cocktail (Roche). Samples
(40 mg each) were electrophoresed on 4–12% NuPAGE Bis-Tris gels,
and transferred onto Immobilon-P membranes (Millipore). Nrf2
was detected with an anti-Nrf2 antibody (R&D Systems) and goat
anti-mouse IgG HRP-conjugate (R&D Systems) using the Visualizer
kit (Upstate Biotechnology) and a Fujiﬁlm LAS-1000 imager (Fuji
Film, Tokyo, Japan). Beta actin (internal control) was detected with
HRP-conjugated anti-β-actin antibody (Abcam).
2.9. Non-haem and serum Iron Measurements
Quantitative measurement of non-haem iron was performed
according to the method of Torrance and Bothwell [23]. Results
were reported as micrograms iron/gram of tissue dry weight.
Serum iron was measured using an iron binding assay kit (Pierce).
Results were reported as micrograms of iron/decilitre.
2.10. Determination of chelatable iron pool by ﬂow cytometry
Nrf2 wild-type and knockout mouse embryonic ﬁbroblasts (MEFs)
were grown on 6-cm dishes (PAA) to conﬂuence in Iscove's modiﬁed
Dulbecco's medium (Invitrogen) supplemented with 10% FBS, insulin-
transferrin-selenium and antibiotics/antimycotics mixtures (Invitro-
gen). For intracellular iron detection, the cells were washed 3X with
PBS and then incubated with PBS (as background ﬂuorescence control)
or in PBS with 5 mM and 10 mM Phen Green SK dipotassium salt (In-
vitrogen) for 20 min. The cells were then washed 3X with PBS and
detached with PBS/0.5 mM EDTA for 5 min. After centrifugation for
5 min at 2000 rpm, the cells were resuspended in 1 ml PBS for FACs
analysis using a CyAn ADP ﬂow cytometer (Beckman Coulter).
2.11. Statistical Analysis
Data were analysed using Microsoft Excel (Microsoft) and graphs
were plotted with GraphPad Prism 5 software (GraphPad, San Diego,
CA). All data were presented as means of duplicates (7S.E.M).3. Results
3.1. Hepcidin transcription by Nrf2 through an antioxidant response
element
We hypothesized that hepcidin senses iron because of the
oxidative stress that iron generates through Fenton-type reactions.
We further conjectured that Nrf2, as the master regulator of stress
responses, might regulate hepcidin expression through this me-
chanism. To examine redox-dependent regulation of hepcidin
expression we subcloned two overlapping DNA fragments en-
compassing 1.8 kb of the human HAMP promoter. We identiﬁed
a putative hepcidin antioxidant response element (HepcARE) at
nucleotides 1732 to 1722 from the initiation codon (Fig. 1A).
Co-transfections of the promoter into HepG2 cells showed dose-
dependent transactivation by Nrf2 (Fig. 1B). We also tested Nrf2
isoforms, Nrf1 and Nrf3, for their abilities to transactivate the
promoter and found differential activation, with Nrf2 inducing the
highest level of promoter activity (Fig. 1C). Sequence comparisons
showed that HepcARE (see Fig. 1A) ﬁts the canonical ARE con-
sensus nTGACnnnGC. This element was also identical to the ARE of
rat QR and was homologous to the AREs of phase II and other
oxidative stress-inducible and cytoprotective genes. Similar se-
quences and spatial arrangements were also found in the pro-
moters of mouse hepcidin 2 (mhepc2) and rat hepcidin genes
(Fig. 1D). Of the two paralogous mouse hepcidin genes, mhepc1 is
considered functionally equivalent to its human orthologue but is
devoid of an ARE in an equivalent position because of a retroviral
element inserted within that region of this gene [24]. However a
putative ARE is present further upstream of the integration;
mhepc2 has an ARE in a spatial arrangement similar to HAMP.
To test whether the putative ARE in HAMP was functional, we
directionally subcloned it and its mutant into a luciferase vector
under the control of the SV40 promoter. Transient transfection of
these enhancer constructs showed that the wild-type ARE con-
struct enhanced luciferase expression and that this was differen-
tially inducible by polyphenols compared with DMSO; however
this expression was reduced to background expression levels with
the mutant ARE construct (Fig. 1E). This conﬁrmed that HepcARE
was functional and necessary for responsiveness to prototypical
Nrf2 inducers.
3.2. Phytoestrogens induce HAMP expression in vitro and in vivo
Since we found that polyphenolic antioxidants could activate
HepcARE, we asked whether they could induce hepcidin expression.
To determine this, HepG2 cells were treated with selected phytoes-
trogens and RNA was extracted after 6 h for RT-PCR. This showed
differential induction of HAMP mRNA expression by these molecules
(Fig. 2A); HO-1 was similarly induced by polyphenols (data not
shown). To determine whether phytoestrogens could also induce
Hamp expression in vivo, we injected age-matched rats intra-perito-
neally (IP) with a selection of these compounds (Fig. 2B): (-)-epi-
gallocatechin-3-gallate (EGCG), kaempferol, naringenin, quercetin and
resveratrol; control animals received 0.1% DMSO in normal saline.
After 18 h, we performed RT-PCR on liver RNA and found Hamp in-
duction in polyphenol-treated rats but not in animals which received
only DMSO (Fig. 2C). We also found parallel increases in the expres-
sion of the phase II genes GST and QR1, as well as HO-1 (Fig. 2d–F),
indicating a common signaling pathway for these genes. While we
found only modest induction of all the phase II genes with quercetin,
this polyphenol induced a massive increase in hepcidin expression
(over 500-fold); this differential effect cannot be easily explained. Al-
though this could be attributed to synergism between Nrf2 and the
JAK/STAT3 pathway, we discounted that possibility because quercetin
represses IL-6 signaling [25,26]. We therefore propose that alternative
Fig. 1. HAMP regulation by Nrf2 through an antioxidant response element. (A) Promoter constructs. Luciferase expression is driven from the native HAMP promoter and
transcription start site (PHamp) in HepcP1.8luc while transcription initiation site in Hepc0.7luc is provided by a minimal SV40 promoter (PSV40). (B) Dose-dependent trans-
activation of HAMP promoter by Nrf2. (C) Differential activation of HAMP promoter by Nrf2 and its isoforms. (D) Comparison of HepcARE with the AREs of other cyto-
protective genes and putative AREs in hepcidin orthologues: metallothionein, ferritin (mouse, HO-1, QR1 and GST-Ya; the v-Maf recognition sequence is also shown. (E)
Polyphenols differentially activate HepcARE. HepcARE-luc and its mutant HepcAREMt-luc (both under the control of PSV40) were transfected into HepG2 cells and treated
with either DMSO or polyphenols and with tBHQ. Fold-activation is with respect to luciferase expression in DMSO-treated cells.
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Hepcidin hyper-induction by quercetin correlated with changes in
serum iron levels and transferrin saturation in the animals; the other
polyphenols did not induce any changes in these parameters (Fig. 3A
and B). We also measured hepatic Fpn mRNA levels by RT-PCR and
found a signiﬁcant reduction in the livers of quercetin-treated com-
pared with DMSO-fed rats (Fig. 3C). Polyphenols induce a large
number of microRNAs [27] one of which, miR-17-3p, we previously
found to be strongly induced by quercetin [28]. This microRNA re-
presses Fpn transcription in intestinal cells by targeting its 3'UTR. We
speculate that miR-17-3p rather than hepcidin may have contributed
to the post-transcriptional repression of Fpn we found. Paradoxically,
other work suggests that Fpn itself may be up-regulated by Nrf2 in
mouse splenic macrophages [29]. However previous reports and our
own (unpublished) observations suggest that Fpn regulation by iron or
pro-inﬂammatory stimuli may be cell or tissue-speciﬁc, and may not
be dependent on hepcidin [30,31]. The possibility of other iron-reg-
ulatory molecules such as lipocalin 2 [32] impinging on the hepcidin-
Fpn axis cannot be ruled out.
3.3. Derepression of Nrf2 from Keap1 by dietary polyphenols/
phytoestrogens
As Nrf2 couples with Keap1 to form a redox sensor, we asked if
they could regulate hepcidin expression. Co-transfection of Keap1
[14] or Bach1 [33] with the full-length promoter and Nrf2 showed
dose-dependent luciferase repression by Keap1 (Fig. 4A, left pa-
nel). Similarly Bach1 dose-dependently repressed promoteractivity (Fig. 4A, right panel), consistent with the ability of these
proteins to repress Nrf2 target genes. We next asked whether
these phytoestrogens could derepress Nrf2 from Keap1. To test
this, we transfected cells with the promoter or enhancer con-
structs and treated the cells with selected phytoestrogens; we
found that these compounds differentially relieved Nrf2 repres-
sion by Keap1, restoring luciferase expression to levels similar to
those with Nrf2 alone (Fig. 4B–D). Nrf2 derepression by the phy-
toestrogens was much higher than could be expected from its
simple release from Keap1, suggesting that these compounds may
amplify the activity of other components of the Nrf2 signaling
pathway. As a positive control, we also tested the chalcone deri-
vative and Nrf2 activator, 2-triﬂuoromethyl-2′-methoxychalone
[34] for HAMP promoter derepression from Keap1. This small
molecule (at 10 mM) induced promoter activity 30-fold com-
pared with resveratrol, quercetin, naringenin and kaempferol;
Keap1 repressed this effect (Fig. 4E).
3.4. Nrf2 synergizes with c-Jun to regulate HAMP transcription
Since Nrf2 interacts with other members of the basic leucine-zipper
(bZIP) transcription factor family in redox-dependent gene regulation
[35,36], we asked if c-Jun and/or c-Fos homo- or heterodimers, might co-
operate with Nrf2 to regulate hepcidin expression. We transfected the
promoter with c-Fos, wild-type c-Jun and its dominant-negative mutant
c-JunbZIP; this lacks the dimerization domain.We found that while wild-
type c-Jun markedly increased promoter activity, c-JunbZIP was com-
paratively less potent (Fig. 5A); c-Fos activated the promoter less robustly
Fig. 2. Induction of hepcidin and phase II gene expression by polyphenols. (A) RT-PCR of HAMP mRNA in HepG2 cells treated with 100 mM polyphenols or DMSO for 6 h. (B)
Structures of polyphenols used for in vivo study. Kaempferol (ﬂavonol), Naringenin (ﬂavanone), quercetin (ﬂavonol), resveratrol (stilbene) and EGCG (tea catechin). Rats were
injected intra-peritoneally with either DMSO or with selected polyphenols for 18 h; liver RNA was extracted and analysed by qRT-PCR for the expression of: (C) Hamp; (D)
Quinone reductase (QR1); (E) Glutathione S-transferase (GST), and (F) Heme oxygenase 1 (HO-1). All target mRNA levels were normalized to GAPDH internal control.
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in HAMP transcription, we co-transfected them with HepcP1.8luc. We
found that Nrf2-dependent increase in promoter activity was enhancedby c-Jun but not by c-Fos (Fig. 5C). Promoter transactivation by Nrf2 and
c-Jun was synergistic but non-additive, i.e. promoter activity was higher
than a summation of their individual activities.
Fig. 3. Hepcidin induction by polyphenols in vivo correlates with changes in: (A) Systemic iron levels, and (B) Transferrin saturation. (C) Hepcidin up-regulation by quercetin
is inversely correlated with Fpn expression in rat liver.
Fig. 4. Polyphenols and the Nrf2 activator 2-triﬂuoromethyl-2′-methoxychalcone derepress Nrf2 from Keap1. (A) Keap1 and Bach1 dose-dependently repressed HAMP
transcription by Nrf2. HepcP1.8-luc was transfected alone or with 100 ng Nrf2 and increasing concentrations of Keap1 or Bach1. (B) HepcARE, (C) HepcP0.7ARE-luc and (D)
HepcP1.8-luc were transfected alone or with Nrf2 into HepG2 cells. Where indicated, Keap1 was co-transfected with Nrf2. The cells were treated with DMSO or polyphenols.
(E). HepcP1.8-luc was co-transfected with Nrf2 and Keap1; cells were treated for 24 h with resveratrol, quercetin and kaempferol or with DMSO and the Nrf2 activator
2-triﬂuoromethyl-2′-methoxychalcone as negative and positive controls respectively. In all cases except DMSO, Nrf2 was derepressed from Keap1.
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Fig. 5. Synergy between Nrf2, bZIP family members and chromatin modiﬁers in hepcidin regulation. (A) Dose-dependent increase in hepcidin transcription by wild-type but
c-Jun but not its dominant-negative mutant; (B) Comparative hepcidin regulation by c-Fos; (C) Transcriptional synergy between Nrf2 and c-Jun but not c-Fos in hepcidin
regulation; compare with (A). (D) BRG1enhances Hamp transcription by Nrf2. Nrf2 was transfected alone or with SW1/SNF subunits BRG1 or BRM. (E) Dose-dependent Hamp
repression by dominant-negative BRG1.
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modelling factors
Chromatin modiﬁers of the BAF chromatin-remodelling com-
plex regulate diverse genes including those involved in the in-
ﬂammatory response [37,38]. For example, Brahma-related gene 1
(BRG1/SMARCA4), has been shown to regulate HO-1 transcription
[39]. We found that co-transfection of BRG1 and its relative
BRAHMA, BRM, increased basal hepcidin promoter activity. How-
ever, only BRG1 could enhance hepcidin promoter activity when
co-expressed with Nrf2 (Fig. 5D) while its dominant-negative
mutant BRG1DN repressed it (Fig. 5E). Thus although BRM sup-
ports higher basal promoter activity than BRG1, compared with
the latter it did not synergize with Nrf2 in HAMP promoter trans-
activation. This may be because only BRG1 is capable of interacting
with leucine zipper transcription factors (of which c-fos, c-Jun and
Nrf2 are members), while BRM prefers ankyrin repeat proteins ofthe Notch signaling pathway [40,41]. Thus BRG1 appears to be the
preferred partner in Nrf2 transactivation of hepcidin expression.
3.6. Nrf2 recruitment to the hepcidin promoter through HepcARE
To determine the speciﬁcity of the interaction between Nrf2 and
HepcARE, we performed electrophoretic mobility shift assays using
nuclear extracts from HepG2 cells treated with DMSO or selected
phytoestrogens, as well as with hemin and Fe2þ . In these assays we
found increased binding of the oligonucleotide using nuclear extracts
from polyphenol-treated cells compared with those from DMSO-
treated cells (Fig. 6A). This binding could be competitively inhibited by
excess unlabeled HepcARE (lane 5); mutant HepcARE could not bind
to the nuclear component and compared with control we found only
modest binding in nuclear extracts from cells treated with FeSO4
(Fig. 6A, lanes 2and 9 respectively). To conﬁrm Nrf2 binding to Hep-
cARE, we used recombinant Nrf2 and MafG in mobility shift assays.
Fig. 6. Recruitment of Nrf2 to the hepcidin promoter occurs via the ARE. (A) EMSA with HepcARE and nuclear extracts from HepG2 cells treated with 2, DMSO; 4, tBHQ
(100 mM); 6, quercetin (50 mM); 7, sulforaphane (10 mM); 8, resveratrol (100 mM); 9, hemin (100 mM) and 10, FeSO4 (200 mM). Lane 1 contains HepcARE without nuclear
extract; lanes 3 and 5 contained nuclear extract from quercetin-treated cells incubated with HepcAREMt or with 100-fold molar excess of cold HepcARE respectively. (B)
EMSA with recombinant GST-Nrf2 and His-MafG. 1, HepcARE only; 2, HepcARE plus puriﬁed GST (as negative control); 3, HepcARE/His-MafG; 4, HepcARE/GST-Nrf2; 5-7,
HepcARE/His-MafG plus increasing concentrations of GST-Nrf2; 8, Competition with excess cold HepcARE interferes with HepcARE binding by His-MafG/GST-Nrf2 het-
erodimers; 9, Competition with non-speciﬁc oligonucleotide (NSO) for GST-Nrf2/His-MafG binding; 10, HepcAREMt plus His-MafG/GST-Nrf2 heterodimers. (C) ChIP assay.
HepG2 cells were treated with DMSO, 1 μg/mL LPS, quercetin (50 μM), sulforaphane (10 μM), and tBHQ (100 μM). PCR of cross-linked chromatin immunoprecipitated with a
non-speciﬁc IgG, lane 2 (-), or with an anti-Nrf2 antibody (þ), lane 3; lane 1 contains PCR from input chromatin (I). DNA molecular size markers are shown for comparison.
(D) Nrf2 is induced by polyphenols. Western blot of total lysates of HepG2 cells treated with DMSO or 100 μM kaempferol, naringenin, quercetin, and resveratrol for 6 h. (E)
Nrf2 is up-regulated by effectors of hepcidin expression. HepG2 cells were treated for 6 h with DMSO or with LPS, IL-6, Cd and with increasing concentrations of FeNTA. β-
actin expression was used as internal standard.
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homodimers bound to this element. When Nrf2 was incubated at
increasing concentrations with MafG, we found a dose-dependentincrease in HepcARE binding. This was diminished by competition
with cold HepcARE (Fig. 6B, lane 8) but not with a non-speciﬁc oli-
gonucleotide (lane 9), while the mutant ARE showed reduced binding
H.K. Bayele et al. / Free Radical Biology and Medicine 89 (2015) 1192–12021200to Nrf2/MafG heterodimers (Fig. 6B, lane 10). This showed conclusively
that Nrf2/MafG heterodimers bind to HepcARE.
As a ﬁnal test of Nrf2 recruitment to the HAMP promoter at the
genomic level, we performed ChIP assays. Upon treating HepG2 cells
with quercetin, and tBHQ and the isothiocyanate sulforaphane, we
immunoprecipitated that region of the promoter with HepcARE using
an anti-Nrf2 antibody but not from cells treated with DMSO or when
chromatin was immunoprecipitated with a non-speciﬁc IgG of the
same isotype. Interestingly, LPS treatment increased hepcidin pro-
moter occupancy by Nrf2 far more than the phytoestrogens did
(Fig. 6C); this is consistent with other observations that LPS rapidly
induces Nrf2, HO-1 and quinone reductase expression [42].
3.7. Hepcidin effectors induce Nrf2 expression
We further conﬁrmed Nrf2 induction by Western blotting; this
showed that compared with DMSO, phytoestrogens increased Nrf2Fig. 7. Intracellular staining of labile iron pool shows that Nrf2 regulates iron loading. (
(blue trace) or treated with 5 mM (red trace) and 10 mM (green trace) Phen Green SK. Ce
Phen Green ﬂuorescence (as a measure of the amount of chelatable or labile iron pool)protein levels in HepG2 cells (Fig. 6D). We also tested other effectors of
hepcidin expression that includes both biotic (IL-6 and LPS) and abiotic
(Fe2þ and Cd)) inducers to see if they could also induce Nrf2 ex-
pression. We treated HepG2 cells with these stimuli, and increasing
concentrations of FeNTA. Western blotting showed that compared
with untreated controls, Nrf2 was highly expressed in cells treated
with IL-6, LPS, and FeNTA as well as by Cd (Fig. 6E). Taken together,
these observations show that the effectors of hepcidin expression also
activate Nrf2; this is consistent with a common signaling pathway.
3.8. Nrf2 deletion causes intracellular iron accumulation
We hypothesized that Nrf2 might regulate iron-overload in-
duced toxicity. To test this we treated mouse embryonic ﬁbroblasts
(MEFs) from wild-type and Nrf2 knockout mice with Phen Green
SK [43], a green ﬂuorescent indicator of intracellular iron, to de-
termine differences in chelatable iron pools. FACs analysis (Fig. 7AA) Nrf2/ (knockout) and (B) wild-type (Nrf2 þ/þ) MEFs were either untreated
lls were subjected to FACs analysis as described above. (C) Quantiﬁcation of relative
in knockout and wild-type MEFs.
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more chelatable labile iron compared with wild-type MEFs
(Fig. 7C).4. Discussion
We know much more about the role of hepcidin in iron
homeostasis than we do about its designed function as a defensin.
Here our observations suggest that Nrf2 might integrate both
functions through its role as the primary transcriptional regulator
of cellular defense responses. We showed that Nrf2 up-regulated
hepcidin transcription from an ARE that bound Nrf2/MafG het-
erodimers. We also found that polyphenols or phytoestrogens
commonly found in fruits and vegetables could induce the ex-
pression of hepcidin as well as other defense genes in rats. In vitro,
these small molecules seemed able to relieve Nrf2 repression as
shown by their ability to reactivate hepcidin promoter silencing by
Keap1. This may be related to the ability of similar molecules to
inhibit Keap1-dependent Nrf2 ubiquitination and proteasomal
degradation [44].
While the link between iron and Nrf2 is less obvious than it is
with hepcidin, it might be inferred from the ability of free iron to
induce oxidative stress. Iron overload causes several diseases for
this reason and in all of them, Nrf2 is implicated; these include
type 2 diabetes, steatohepatitis, the metabolic syndrome, ageing,
inﬂammatory and cardiovascular diseases, neurodegeneration and
cancer [20,45–47]. Nrf2 involvement in iron-related diseases is
supported by other studies which showed that FeNTA induced
nephrotoxicity in Nrf2-knockout but not in wild-type mice. Pro-
tection from kidney damage was coincident with the induction of
Nrf2 and its target genes, while priming with Nrf2 inducers before
FeNTA administration also conferred protection [48,49]. While this
manuscript was in preparation, Silva-Gomes et al. [50] reported
that Nrf2 could protect mice against iron-overload induced injury.
This supports our ﬁndings that MEFs from Nrf2-knockout mice
were more susceptible to iron-overload than wild-type MEFs.
Further, Nrf2 knockout mice accumulated signiﬁcantly more liver
iron than wild-type mice [51]. Taken together, these ﬁndings im-
plicate Nrf2 in iron homeostasis and in preventing iron-related
toxicity.
Our observation that LPS increased Nrf2 recruitment to the
HAMP promoter is consistent with its role in innate immunity,
tissue repair and regeneration [11,12,52]. Together with other
ﬁndings of hepcidin induction by ER stress [5,6], it appears that
synergies between Nrf2 and other bZIP proteins such as c-Jun and
MafG (as shown in this report) may underlie hepcidin regulation
by biotic and abiotic acute stressors. Supporting evidence of hep-
cidin regulation by the Nrf2-Keap1 axis also come frommicroarray
analyses of mouse liver RNA. Along with other proteins required
for cell survival and proteostasis, hepcidin was induced when mice
were fed the chemopreventive agent 3H-1,2-dithiole-3-thione
[53]. Our ﬁndings therefore suggest that hepcidin regulation may
be under the same Nrf2 transcriptional circuitry that guides the
expression of ﬁrst responders for oxidative stress defense and
survival; these include detoxiﬁcation enzymes, ferritin, HO-1 and
MT-1 [3,8,10,42], and proteins encoded by the immediate early
response genes c-fos, c-jun and c-myc [54]. Synergistically, these
proteins ensure redox balance and protection against oxidative
stress-related diseases.
Taken together, this report shows that dietary phytoestrogens
may combinatorially control systemic iron levels by up-regulating
hepcidin expression, and could (by extension) prevent some of the
diseases associated with iron-induced toxicity indicated above. In
general, phytoestrogens have a hormetic effect on human health,
conferring protection against many oxidative-stress associatedpathologies. Some reports suggest that quercetin and related
polyphenols such as EGCG may reduce iron toxicity by chelation or
by preventing its release/efﬂux from cells [55,56]. It was particu-
larly intriguing that of all the compounds tested, quercetin had the
most dramatic effect on post-prandial hepcidin induction, serum
iron and transferrin saturation. This may partly explain their
ability to reduce iron overload in haemochromatosis [57]. Our
ﬁndings therefore indicate that by inducing hepcidin expression,
phytoestrogens may be useful adjunctive nutraceuticals for con-
trolling diseases of iron overload and also for preventing the se-
quelae of iron-induced toxicity such as hepatitis, cirrhosis, ne-
phrotoxicity and carcinogenesis [44,47–49,58—60].Potential conﬂict of interest
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